BioSpace News Archive

Genetown

Akebia Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Akebia Therapeutics today announced that the Company granted six newly-hired employees options to purchase an aggregate of 30,500 shares of Akebia’s common stock with a per share exercise price of $14.87, the closing price on the grant date.

January 2, 2018
·
1 min read
Business

Aerie Pharmaceuticals Announces Appointment of Julia Williams as Director of Medical Affairs

Aerie announced the appointment of Julia Williams as Director of Medical Affairs, reporting to John Maltman, Ph.D., Aerie’s Vice President of Medical Affairs.

January 2, 2018
·
5 min read
Bone Index Announces AMA Issues New Reimbursement Code for Bindex Osteoporosis Measurement

Bone Index announces that the AMA has issued a new Category III CPT code* for Bindex measurement to help physicians in diagnosing osteoporosis.

January 2, 2018
·
2 min read
BioCapital

Celgene Co-Founder Bags $23M for Johns Hopkins Spinout NexImmune

In conjunction with the financing, Tony Yao, MD, PhD, a Partner at ArrowMark Partners, will join NexImmune’s Board of Directors.

January 2, 2018
·
3 min read
Business

PharmaMar Signs a Commercialization and Distribution License Agreement for Aplidin (plitidepsin) With Megapharm in Israel

PharmaMar has announced today a commercialization and distribution license agreement with Megapharm for the marine-derived anticancer drug Aplidin in Israel and the territory known as the Palestinian Authority.

January 2, 2018
·
1 min read
Compugen Announces Presentations at Three Upcoming Cancer Immunotherapy Conferences

The poster titled “PVRIG Expression is Associated with T Cell Exhaustion and Synergizes with TIGIT to Inhibit Anti-Tumor Responses” will be presented on Thursday, January 18, 2018 at the Keystone Symposia Conference

January 2, 2018
·
4 min read
Drug Development

Progenics Pharmaceuticals Completes Enrollment in Phase III Study of PSMA-Targeted Imaging Agent 1404

Top-line data is expected in 3Q2018.

January 2, 2018
·
5 min read
Business

Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications

Ms. Webb is a CFA charterholder and joins Radius from Genfit Corporation where she was Vice President and Head of Investor Relations.

January 2, 2018
·
1 min read
Business

Promore Pharma Adjusts Plans for PXL01 in North America

Promore Pharma today announced that it will continue and widen its efforts to seek funding for a Phase III clinical trial on PXL01 in North America.

January 2, 2018
·
4 min read
Business

OncoResponse Expands Scientific Leadership With the Addition of Dr. Anil Singhal as CSO and Dr. Kamal D. Puri as VP, R&D

OncoResponse today announced it has expanded its scientific leadership through the additions of Anil Singhal, Ph.D., and Kamal D. Puri, Ph.D., to the management team.

January 2, 2018
·
2 min read